Takara Bio Inc. (OTCMKTS:TKBIF) Short Interest Update

Takara Bio Inc. (OTCMKTS:TKBIFGet Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 86,800 shares, a growth of 50.4% from the March 31st total of 57,700 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ? days.

Takara Bio Price Performance

OTCMKTS TKBIF opened at $23.20 on Wednesday. Takara Bio has a 1-year low of $23.20 and a 1-year high of $23.20. The stock has a 50-day moving average of $23.20 and a 200-day moving average of $23.20.

About Takara Bio

(Get Free Report)

Takara Bio Inc, together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names.

Further Reading

Receive News & Ratings for Takara Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takara Bio and related companies with MarketBeat.com's FREE daily email newsletter.